Bivalirudin versus heparin as an antithrombotic agent in patients who undergo percutaneous saphenous vein graft intervention with a distal protection device

Seung-Woon Rha, Pramod K. Kuchulakanti, Rajbabu Pakala, Edouard Cheneau, Ellen Pinnow, Rebecca Torguson, Augusto D. Pichard, Lowell F. Satler, William O. Suddath, Kenneth M. Kent, Joseph Lindsay, Ron Waksman

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Bivalirudin (Angiomax) is increasingly used as a substitute for heparin in a variety of percutaneous coronary interventions, and data on its usage in saphenous vein graft interventions are limited. This retrospective, observational study evaluated the efficacy and safety of bivalirudin compared with heparin as an antithrombotic regimen in patients who underwent saphenous vein graft intervention with distal protection devices. We found that bivalirudin use is clinically safe and feasible, with fewer vascular and ischemic complications compared with heparin.

Original languageEnglish
Pages (from-to)67-70
Number of pages4
JournalAmerican Journal of Cardiology
Volume96
Issue number1
DOIs
Publication statusPublished - 2005 Jul 1
Externally publishedYes

Fingerprint

Fibrinolytic Agents
Saphenous Vein
Heparin
Transplants
Equipment and Supplies
Percutaneous Coronary Intervention
Observational Studies
Blood Vessels
Retrospective Studies
Safety
bivalirudin

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Bivalirudin versus heparin as an antithrombotic agent in patients who undergo percutaneous saphenous vein graft intervention with a distal protection device. / Rha, Seung-Woon; Kuchulakanti, Pramod K.; Pakala, Rajbabu; Cheneau, Edouard; Pinnow, Ellen; Torguson, Rebecca; Pichard, Augusto D.; Satler, Lowell F.; Suddath, William O.; Kent, Kenneth M.; Lindsay, Joseph; Waksman, Ron.

In: American Journal of Cardiology, Vol. 96, No. 1, 01.07.2005, p. 67-70.

Research output: Contribution to journalArticle

Rha, S-W, Kuchulakanti, PK, Pakala, R, Cheneau, E, Pinnow, E, Torguson, R, Pichard, AD, Satler, LF, Suddath, WO, Kent, KM, Lindsay, J & Waksman, R 2005, 'Bivalirudin versus heparin as an antithrombotic agent in patients who undergo percutaneous saphenous vein graft intervention with a distal protection device', American Journal of Cardiology, vol. 96, no. 1, pp. 67-70. https://doi.org/10.1016/j.amjcard.2005.02.047
Rha, Seung-Woon ; Kuchulakanti, Pramod K. ; Pakala, Rajbabu ; Cheneau, Edouard ; Pinnow, Ellen ; Torguson, Rebecca ; Pichard, Augusto D. ; Satler, Lowell F. ; Suddath, William O. ; Kent, Kenneth M. ; Lindsay, Joseph ; Waksman, Ron. / Bivalirudin versus heparin as an antithrombotic agent in patients who undergo percutaneous saphenous vein graft intervention with a distal protection device. In: American Journal of Cardiology. 2005 ; Vol. 96, No. 1. pp. 67-70.
@article{9bab688b521a4bc1bc60554ac2abd7da,
title = "Bivalirudin versus heparin as an antithrombotic agent in patients who undergo percutaneous saphenous vein graft intervention with a distal protection device",
abstract = "Bivalirudin (Angiomax) is increasingly used as a substitute for heparin in a variety of percutaneous coronary interventions, and data on its usage in saphenous vein graft interventions are limited. This retrospective, observational study evaluated the efficacy and safety of bivalirudin compared with heparin as an antithrombotic regimen in patients who underwent saphenous vein graft intervention with distal protection devices. We found that bivalirudin use is clinically safe and feasible, with fewer vascular and ischemic complications compared with heparin.",
author = "Seung-Woon Rha and Kuchulakanti, {Pramod K.} and Rajbabu Pakala and Edouard Cheneau and Ellen Pinnow and Rebecca Torguson and Pichard, {Augusto D.} and Satler, {Lowell F.} and Suddath, {William O.} and Kent, {Kenneth M.} and Joseph Lindsay and Ron Waksman",
year = "2005",
month = "7",
day = "1",
doi = "10.1016/j.amjcard.2005.02.047",
language = "English",
volume = "96",
pages = "67--70",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Bivalirudin versus heparin as an antithrombotic agent in patients who undergo percutaneous saphenous vein graft intervention with a distal protection device

AU - Rha, Seung-Woon

AU - Kuchulakanti, Pramod K.

AU - Pakala, Rajbabu

AU - Cheneau, Edouard

AU - Pinnow, Ellen

AU - Torguson, Rebecca

AU - Pichard, Augusto D.

AU - Satler, Lowell F.

AU - Suddath, William O.

AU - Kent, Kenneth M.

AU - Lindsay, Joseph

AU - Waksman, Ron

PY - 2005/7/1

Y1 - 2005/7/1

N2 - Bivalirudin (Angiomax) is increasingly used as a substitute for heparin in a variety of percutaneous coronary interventions, and data on its usage in saphenous vein graft interventions are limited. This retrospective, observational study evaluated the efficacy and safety of bivalirudin compared with heparin as an antithrombotic regimen in patients who underwent saphenous vein graft intervention with distal protection devices. We found that bivalirudin use is clinically safe and feasible, with fewer vascular and ischemic complications compared with heparin.

AB - Bivalirudin (Angiomax) is increasingly used as a substitute for heparin in a variety of percutaneous coronary interventions, and data on its usage in saphenous vein graft interventions are limited. This retrospective, observational study evaluated the efficacy and safety of bivalirudin compared with heparin as an antithrombotic regimen in patients who underwent saphenous vein graft intervention with distal protection devices. We found that bivalirudin use is clinically safe and feasible, with fewer vascular and ischemic complications compared with heparin.

UR - http://www.scopus.com/inward/record.url?scp=20744456941&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20744456941&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2005.02.047

DO - 10.1016/j.amjcard.2005.02.047

M3 - Article

C2 - 15979436

AN - SCOPUS:20744456941

VL - 96

SP - 67

EP - 70

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 1

ER -